An Australian-first study has found that certain natural fats which exist in the skin of babies, called lipids, are linked to the development of eczema in children.
Mar 21, 2025
0
1
Once-daily roflumilast cream 0.05% is safe and effective for atopic dermatitis (AD) in patients ages 2 to 5 years, according to a study published online Feb. 20 in Pediatric Dermatology.
Mar 14, 2025
0
0
For patients with interstitial cystitis/bladder pain syndrome (IC/BPS), bladder wall thickness (BWT) on computed tomography (CT) scans reflects the severity of bladder inflammatory conditions, according to a study published ...
Mar 7, 2025
0
1
For adults with severe alopecia areata (AA), ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, at doses of 4 and 8 mg is efficacious and tolerable, according to a study presented at the annual meeting of the American ...
Mar 13, 2025
0
0
New research from RCSI University of Medicine and Health Sciences has found that white blood cells which 'remember' past inflammatory events are quick to overreact, raising the risk of blood clots.
Mar 10, 2025
0
28
New research from the Kennedy Institute has revealed how two important proteins, TBK1 and IKKε, play a crucial role in preventing premature cell death, which can lead to serious inflammation in the body. The findings are ...
Mar 28, 2025
0
0
The U.S. Food and Drug Administration has approved Johnson & Johnson's Tremfya (guselkumab) for adult patients with moderately to severely active Crohn disease.
Mar 25, 2025
0
0
Patients with atopic dermatitis (AD) who achieve completely clear skin with tapinarof (Vtama) cream maintain low disease activity after about 80 days off treatment, according to a study presented at the annual meeting of ...
Mar 14, 2025
0
0
In a recent study published in Science Advances, researchers led by Prof. Li Xinjian from the Institute of Biophysics of the Chinese Academy of Sciences have uncovered a novel immunoregulatory function of isocyanic acid (ICA), ...
Mar 13, 2025
0
0
A research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation. A study shows that the semi-synthetic bile acid NorUDCA inhibits in the intestine the formation ...
Mar 13, 2025
0
0
